CORRECTION article

Front. Immunol., 29 May 2025

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1625107

This article is part of the Research TopicModulating Plasmacytoid Dendritic Cells: Balancing Cancer Immunity and Tumor ProgressionView all 3 articles

Corrigendum: Characterization of TLR9 responsiveness in cell subsets derived from in vitro pDC differentiation of hematopoietic stem and progenitor cells

  • 1Department of Biomedicine, Aarhus University, Aarhus, Denmark
  • 2Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
  • 3Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark
  • 4Department of Pathology and Immunology, Division of Immunobiology, Washington University School of Medicine, St. Louis, MO, United States

A Corrigendum on
Characterization of TLR9 responsiveness in cell subsets derived from in vitro pDC differentiation of hematopoietic stem and progenitor cells

by Sánchez Hernández S, Bjerg TW, Nielsen IH, Laustsen A, Q Tang H, Pedersen LH, Klechevsky E, Jakobsen MR and Bak RO (2025). Front. Immunol. 16:1550397. doi: 10.3389/fimmu.2025.1550397

In the published article, there was an error in Figure 8B as published. Figure 8 has been updated. The revised file restores axis label in Figure 8B, which was lost during the article production process. The scientific content remains intact, and the revision ensures the figure is presented as originally intended.

Figure 8
www.frontiersin.org

Figure 8. Comparison of Fc receptor blocking methods in the cell surface staining of subsets derived from HSPC-to-pDC differentiation. (A) Bar graph displaying Transcripts Per Million (TPM) counts of the human pDC markers CD123 (IL3RA) and CD303 (CLEC4C) in each subset. (B) Representative flow cytometry plots showing the cell surface expression of CD123 and CD303 in cells on day 16 of differentiation, employing human IgG alone, TruStain alone, or a combined blocking approach. (C) Flow cytometry histograms illustrating the CD303 expression profile obtained following the indicated blocking method. (D) Bar graphs showing the proportion of CD303 positive cells within hLin and CD11c negative cells (left) and the CD303 surface expression levels (MFI) (right) using various blocking methods during surface staining. Data are presented as mean ± SD from two donors. (E) Bar graph showing Transcripts Per Million (TPM) counts of the Fc gamma receptor I (Fc γRI; FCGR1A).

In the published article, some graphical elements, such as text boxes and axes, were inadvertently omitted of Supplementary Figures S1A, S5, and S6 during the production process. The missing material has been updated in the original article.

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: plasmacytoid dendritic cells, CD34 hematopoietic stem cells, in vitro differentiation, subsets, type I IFN

Citation: Sánchez Hernández S, Bjerg TW, Helstrup Nielsen I, Laustsen A, Q Tang H, Henning Pedersen L, Klechevsky E, Jakobsen MR and Bak RO (2025) Corrigendum: Characterization of TLR9 responsiveness in cell subsets derived from in vitro pDC differentiation of hematopoietic stem and progenitor cells. Front. Immunol. 16:1625107. doi: 10.3389/fimmu.2025.1625107

Received: 08 May 2025; Accepted: 12 May 2025;
Published: 29 May 2025.

Edited and Reviewed by:

William Vermi, ASST Spedali Civili di Brescia, Italy

Copyright © 2025 Sánchez Hernández, Bjerg, Helstrup Nielsen, Laustsen, Q Tang, Henning Pedersen, Klechevsky, Jakobsen and Bak. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Rasmus O. Bak, YmFrQGJpb21lZC5hdS5kaw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.